Skip to main content

Oxurion N.V. (0G99.L)

London Stock Exchange Healthcare Medical - PharmaceuticalsView data quality →
36.4Poor

ValueMarkers Composite Index

Top 2%#43,856 of 44,722

DCF data not available

Piotroski
3/9
Weak
Beneish
5.00
High Risk
Altman
-29.88
Distress
DCF Value
-
N/A
ROIC
2.6%
Low
P/E
0.0
Value
Updated: ·Source: Data sourced from SEC filings and institutional providers. Not financial advice.·Report data issue

Oxurion N.V. (0G99.L) — VMCI valuation read

Composite valuation read on 0G99.L: VMCI 36/100 against a Healthcare sector median of 50. The 14-point below-median print is the headline number for Oxurion N.V., and at the mid-cap tier it reflects how the five pillars combine into a single decision-grade score.

Trailing 30-day insider activity for 0G99.L: nothing material on SEC EDGAR. With the Form 4 channel quiet, the price-vs-DCF gap and the trailing margin trend carry more weight in the active read.

**Investor frame.** Value, quality, risk in three lines on 0G99.L: 0G99.L trades at 25.0x earnings, 39% above the Healthcare median of 18.0x; ROIC of 17.0% sits 7.0pp above the Healthcare median (10.0%); net debt to EBITDA of 1.0x leaves covenant headroom. EV/EBITDA at 14.0x versus 12.0x for Healthcare closes the value frame.

0G99.L fell 0.9% over the trailing 7 days, with a -13.3% read on a 30-day basis.

Top peers ranked by VM Score. Compare valuation, quality, and risk metrics across the sector.

Browse More

Weekly Stock Analysis - Free

5 undervalued stocks, fully modeled. Every Monday. No spam.

Cookie Preferences

We use cookies to analyze site usage and improve your experience. You can accept all, reject all, or customize your preferences.